Clinics and Research in Hepatology and Gastroenterology

Papers
(The H4-Index of Clinics and Research in Hepatology and Gastroenterology is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
An unusual colonic mass in a phlebosclerosis patient84
Contents58
Editorial board53
Contents52
Non-invasive diagnosis and follow-up in liver transplantation50
Use of PNPLA3, TM6SF2, and HSD17B13 for detection of fibrosis in MASLD in the general population44
Effects of saroglitazar in the treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis: A systematic review and meta-analysis41
Acute liver failure: Beyond the guidelines, the challenge of liver support therapies29
Mitochondrial dysfunction in drug-induced hepatic steatosis: Recent findings and current concept27
A case of Vonoprazan-induced collagenous colitis associated with eosinophilic gastroenteritis27
Editorial board26
Serrated lesion detection 2.0: Of blurred vessels and luminal overinflation25
Impact of frailty on outcomes and biliary drainage strategies in acute cholangitis: A retrospective cohort analysis25
Chemotherapy use in end-of-life digestive cancer patients: a retrospective AGEO observational study23
A new model based on gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts prognostic outcome after curative resection of solitary hepatocellular carcinoma22
Risk factors for concomitant infectious pancreatic necrosis in patients with severe acute pancreatitis: A systematic review and meta-analysis21
Non-invasive diagnosis and follow-up of portal hypertension21
A case of peri‑stomal ectopic variceal bleeding in a patient with decompensated cirrhosis treated with TIPS placement20
Refractory GERD and systemic sclerosis: The end of a dead end?20
An extracellular matrix-based signature associated with immune microenvironment predicts the prognosis of patients with hepatocellular carcinoma20
Normalization of duodenal mucosa after treatment with Janus kinase (JAK) inhibitor in refractory celiac disease type 220
0.21975111961365